Moderna Stock Jumps 12% Amid Bird Flu and COVID-19 Concerns
Explore why Moderna stock surged nearly 12%, driven by rising bird flu worries and an uptick in COVID-19 cases. Learn more about this market reaction.
Moderna stock surged nearly 12% on rising bird flu concerns and COVID-19 uptick.